132 related articles for article (PubMed ID: 24865752)
1. A pharmacy concierge service to optimize fidaxomicin therapy.
Bookstaver PB; Capino AC; Bookstaver NK
Am J Health Syst Pharm; 2014 Jun; 71(12):986-7. PubMed ID: 24865752
[No Abstract] [Full Text] [Related]
2. Cost-effectiveness of fidaxomicin for Clostridium difficile treatment.
Simon MS
Clin Infect Dis; 2014 Feb; 58(4):603. PubMed ID: 24300043
[No Abstract] [Full Text] [Related]
3. Is fidaxomicin worth the cost? The verdict is still out!
Hartzema AG; Chen C
Clin Infect Dis; 2014 Feb; 58(4):604-5. PubMed ID: 24300046
[No Abstract] [Full Text] [Related]
4. Reply to Simon, Shah et al, and Hartzema and Chen.
Bartsch SM; Umscheid CA; Fishman N; Lee BY
Clin Infect Dis; 2014 Feb; 58(4):605-7. PubMed ID: 24300044
[No Abstract] [Full Text] [Related]
5. An economic analysis: is fidaxomicin worth the cost?
Shah H; Doyle JJ; Belletti DA
Clin Infect Dis; 2014 Feb; 58(4):603-4. PubMed ID: 24300041
[No Abstract] [Full Text] [Related]
6. Fewer recurrent infections of C. difficile seen with fidaxomicin. This new class of antibiotic--the macrocycles--has a greater sustained response against re-infection than vancomycin.
Morrow T
Manag Care; 2011 Jul; 20(7):49-50. PubMed ID: 21848202
[No Abstract] [Full Text] [Related]
7. Fidaxomicin failures in recurrent Clostridium difficile infection: a problem of timing.
Orenstein R
Clin Infect Dis; 2012 Aug; 55(4):613-4. PubMed ID: 22610922
[No Abstract] [Full Text] [Related]
8. Reduction in Clostridium difficile environmental contamination by hospitalized patients treated with fidaxomicin.
Biswas JS; Patel A; Otter JA; Wade P; Newsholme W; van Kleef E; Goldenberg SD
J Hosp Infect; 2015 Jul; 90(3):267-70. PubMed ID: 25728208
[TBL] [Abstract][Full Text] [Related]
9. Fidaxomicin, a new treatment for Clostridium difficile infections.
Epstein L; Golan Y
Drugs Today (Barc); 2012 Feb; 48(2):101-8. PubMed ID: 22384450
[TBL] [Abstract][Full Text] [Related]
10. Fidaxomicin: a minimally absorbed macrocyclic antibiotic for the treatment of Clostridium difficile infections.
Soriano MM; Liao S; Danziger LH
Expert Rev Anti Infect Ther; 2013 Aug; 11(8):767-76. PubMed ID: 23977933
[TBL] [Abstract][Full Text] [Related]
11. Economic assessment of fidaxomicin for the treatment of Clostridium difficile infection (CDI) in special populations (patients with cancer, concomitant antibiotic treatment or renal impairment) in Spain.
Rubio-Terrés C; Cobo Reinoso J; Grau Cerrato S; Mensa Pueyo J; Salavert Lletí M; Toledo A; Anguita P; Rubio-Rodríguez D; Watt M; Gani R
Eur J Clin Microbiol Infect Dis; 2015 Nov; 34(11):2213-23. PubMed ID: 26407619
[TBL] [Abstract][Full Text] [Related]
12. Fidaxomicin: a novel macrocyclic antibiotic approved for treatment of Clostridium difficile infection.
Venugopal AA; Johnson S
Clin Infect Dis; 2012 Feb; 54(4):568-74. PubMed ID: 22156854
[TBL] [Abstract][Full Text] [Related]
13. Cost-effectiveness analysis evaluating fidaxomicin versus oral vancomycin for the treatment of Clostridium difficile infection in the United States.
Stranges PM; Hutton DW; Collins CD
Value Health; 2013; 16(2):297-304. PubMed ID: 23538181
[TBL] [Abstract][Full Text] [Related]
14. Fidaxomicin for the treatment of Clostridium difficile infections.
Drug Ther Bull; 2012 Nov; 50(11):130-2. PubMed ID: 23154594
[TBL] [Abstract][Full Text] [Related]
15. Hypersensitivity reactions associated with fidaxomicin use.
Iarikov DE; Alexander J; Nambiar S
Clin Infect Dis; 2014 Feb; 58(4):537-9. PubMed ID: 24178248
[TBL] [Abstract][Full Text] [Related]
16. Fidaxomicin: a novel macrocyclic antibiotic for the treatment of Clostridium difficile infection.
Crawford T; Huesgen E; Danziger L
Am J Health Syst Pharm; 2012 Jun; 69(11):933-43. PubMed ID: 22610025
[TBL] [Abstract][Full Text] [Related]
17. Fidaxomicin for Clostridium difficile infection.
Linsky A; Gupta K; Hermos JA
N Engl J Med; 2011 May; 364(19):1875; author reply 1875-6. PubMed ID: 21561361
[No Abstract] [Full Text] [Related]
18. Fidaxomicin for Clostridium difficile Infection.
Safdar N; Craig WA
N Engl J Med; 2011 May; 364(19):1875; author reply 1875-6. PubMed ID: 21561360
[No Abstract] [Full Text] [Related]
19. Fidaxomicin versus vancomycin for Clostridium difficile infection.
Louie TJ; Miller MA; Mullane KM; Weiss K; Lentnek A; Golan Y; Gorbach S; Sears P; Shue YK;
N Engl J Med; 2011 Feb; 364(5):422-31. PubMed ID: 21288078
[TBL] [Abstract][Full Text] [Related]
20. Fidaxomicin: a macrocyclic antibiotic for the treatment of Clostridium difficile infection.
Hardesty JS; Juang P
Pharmacotherapy; 2011 Sep; 31(9):877-86. PubMed ID: 21923589
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
